TcrossGlobal

One-Year Outcomes of Transcatheter Tricuspid Valve Repair Using the Pascal System: The CLASP TR Trial

Transcatheter tricuspid valve repair using the Pascal system had a low complication rate, a high 1-year survival rate, and sustained improvement in TR, physical function, and quality of life over 1 year in patients with severe tricuspid regurgitation (TR) who had persistent symptoms despite medical therapy. Dr. Susheel K. Kodali of Columbia University Irving Medical Center, USA, and colleagues reported in the May 9 issue of the Journal of the American College of Cardiology.

The CLASP TR trial enrolled 65 patients diagnosed with severe or very severe TR and persistent sympt...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.